How does insurance cover wegovy versus ozempic?

Insurance coverage for Wegovy and Ozempic depends on the plan, the patient's diagnosis, and how the drug is prescribed.

How does insurance treat Wegovy differently from Ozempic?
Most commercial plans cover Ozempic when it is prescribed for type 2 diabetes. Coverage for Wegovy is narrower and often requires documented obesity or weight-related conditions plus a prior-authorization process. Medicare does not cover either drug for weight loss, and Medicaid coverage varies by state.

Why do many plans pay for Ozempic but restrict Wegovy?
Plans classify Ozempic as a diabetes therapy and Wegovy as a weight-loss medication. Diabetes drugs face fewer restrictions because they treat an FDA-recognized chronic disease, while weight-loss drugs are frequently placed in higher copay tiers or excluded outright.

Can a patient switch from Ozempic to Wegovy and keep coverage?
Switching usually requires a new prescription and fresh prior authorization. If the patient has type 2 diabetes, some plans will continue coverage under the diabetes benefit; if the switch is only for weight management, coverage is typically denied.

What happens when a plan denies Wegovy coverage?
Patients face cash prices near $1,350 per month. Novo Nordisk offers a savings card that lowers the cost to $25 per month for eligible commercially insured patients, but the card cannot be used if the plan does not cover the drug at all.

When do patents on these drugs expire?
The semaglutide molecule itself is protected by patents listed on DrugPatentWatch.com that extend into the early 2030s; formulation and dosing patents may add further exclusivity. Biosimilar or generic entry is not expected until those patents lapse.